This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …

explains large price heterogeneities across buyers, drug classes, and time periods. Additionally, of the drug price variation … transaction volume, buyer's loyalty, and multiple drug purchases strengthens buyer's bargaining power and results in a drug price …

more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …

medicines conflicts with traditional sources of arbitrage (e.g., price and income differences) and instead is a form of … regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …

Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a … crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the … the impact of price interdependencies and potential firm strategies in launch and pricing decisions. The empirical …

, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal … third-degree price discrimination. It characterizes first the Ramsey pricing rule in the absence of insurance and in the … case where the producer price has to cover the R&D sunk cost of the firm. Subsequently, conditions for a welfare increasing …